These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1085 related articles for article (PubMed ID: 15199477)

  • 1. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New medical anticoagulants].
    Choussat R; Montalescot G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins].
    López-Sendón J; López de Sá E; Rubio Sanz R; Delcán Domínguez JL
    Rev Esp Cardiol; 1999; 52 Suppl 1():76-89. PubMed ID: 10364817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
    Ottani F; Ferrini D; Di Pasquale G; Galvani M
    Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin: an antithrombotic agent whose time has come.
    Futterman LG; Lemberg L
    Am J Crit Care; 1999 Jan; 8(1):520-3. PubMed ID: 9987551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudin for prophylaxis and treatment of deep vein thrombosis.
    Kemkes-Matthes B
    Semin Thromb Hemost; 2002 Oct; 28(5):455-8. PubMed ID: 12420241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].
    Husted SE; Nielsen HK
    Ugeskr Laeger; 2010 Oct; 172(42):2888-91. PubMed ID: 21040659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successors to heparin: new antithrombotic agents.
    Turpie AG
    Am Heart J; 1997 Nov; 134(5 Pt 2):S71-7. PubMed ID: 9396637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
    Hirsh J
    Curr Opin Hematol; 1998 Sep; 5(5):360-5. PubMed ID: 9776217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency.
    Lim W; Al Saleh K; Douketis JD
    Thromb Res; 2006; 118(3):409-16. PubMed ID: 16026817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparins in clinical practice.
    Hunt D
    South Med J; 1998 Jan; 91(1):2-10. PubMed ID: 9438394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
    Nicolau JC; Cohen M; Montalescot G
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):440-5. PubMed ID: 19365279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.